CDC Interim Guidance for COVID-19 Booster Vaccinations
- Centers for Disease Control and Prevention
- All Healthcare Organizations
Last week the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series. Today’s StayAlert! Notice reviews the U.S. Centers for Disease Control and Prevention’s (CDC) interim guidance reflecting the FDA’s authorization.
The CDC recommends a Pfizer-BioNTech COVID-19 booster shot to help increase their pro…Sign Up for Free Trial